Melanoma: all 3,073 studies

Page 11 of 31. Open to participants first (529), then studies with results posted, then the rest; newest registration first within each.

• GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive MelanomaCompletedNCT01245062Phase 3Results posted
• Cell Therapy for Metastatic Melanoma Using CD8 Enriched Tumor Infiltrating LymphocytesTerminatedNCT01236573Phase 1/2Results posted
• A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) MelanomaCompletedNCT01227889Phase 3Results posted
• A Study of Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM )CompletedNCT01227551Phase 2Results posted
• CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic CancerTerminatedNCT01218867Phase 1/2Results posted
• RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast CancerTerminatedNCT01217411Phase 1/2Results posted
• Evaluation of a New Anti-cancer Immunotherapy in Patients With Non-operable and Progressing Metastatic Cutaneous MelanomaCompletedNCT01213472Phase 1Results posted
• Study to Assess the Tolerability of a Bispecific Targeted Biologic IMCgp100 in Malignant MelanomaCompletedNCT01211262Phase 1Results posted
• Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal MelanomaTerminatedNCT01200342Phase 2Results posted
• STA-9090(Ganetespib) in Metastatic Ocular MelanomaCompletedNCT01200238Phase 2Results posted
• Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic MelanomaCompletedNCT01196416Phase 1/2Results posted
• A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in MelanomaCompletedNCT01174238Phase 2Results posted
• Temsirolimus/AZD 6244 for Treatment-naive With BRAF Mutant Unresectable Stage IVTerminatedNCT01166126Phase 2Results posted
• A Pharmacokinetic and Metabolism Study of 14C-labeled RO5185426 on Patients With Metastatic MelanomaCompletedNCT01164891Phase 1Results posted
• A Study of Bevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic MelanomaCompletedNCT01164007Phase 2Results posted
• Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal CancerTerminatedNCT01160445Phase 2Results posted
• A Study of GSK2118436 in BRAF Mutant Metastatic MelanomaCompletedNCT01153763Phase 2Results posted
• Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent MelanomaCompletedNCT01152788Phase 2Results posted
• Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin CancerCompletedNCT01149343Phase 1Results posted
• Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the EyeCompletedNCT01143402Phase 2Results posted
• An Open-Label, Dose-Escalation Study of IMC-20D7S In Participants With Malignant MelanomaCompletedNCT01137006Phase 1Results posted
• An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV MelanomaCompletedNCT01136967Phase 2Results posted
• Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by SurgeryActive, not recruitingNCT01134614Phase 2Results posted
• E7080 (Lenvatinib) in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV MelanomaCompletedNCT01133977Phase 1/2Results posted
• Study of Denileukin Diftitox in Participants With Stage IIIC and Stage IV MelanomaCompletedNCT01127451Phase 2Results posted
• High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With MelanomaCompletedNCT01124734Phase 2Results posted
• Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV MelanomaTerminatedNCT01120275Phase 2Results posted
• Ipilimumab + Temozolomide in Metastatic MelanomaCompletedNCT01119508Phase 2Results posted
• Prospective Randomized Comparative Study of Cell Transfer Therapy Using CD8+-Enriched Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Compared to High-Dose Aldesleukin in M...CompletedNCT01118091Phase 2Results posted
• Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Stage III and Stage IV MelanomaCompletedNCT01107665Phase 2Results posted
• A Pharmacokinetic/Pharmacodynamic Study of RO5185426 in Previously Treated Patients With Metastatic MelanomaCompletedNCT01107418Phase 1Results posted
• Breast and Melanoma Trial With Lymphoseek to Identify Lymph NodesCompletedNCT01106040Phase 3Results posted
• Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic ImbalanceCompletedNCT01100528Phase 2Results posted
• Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged MelanomaTerminatedNCT01092728Phase 2Results posted
• Safety Study of Adjuvant Vaccine to Treat Melanoma PatientsCompletedNCT01079741Phase 1/2Results posted
• SciBase International Melanoma Pivotal StudyCompletedNCT01077050Not applicableResults posted
• A Study of Avastin (Bevacizumab) in Combination With Fotemustine in Patients With Metastatic MelanomaCompletedNCT01069627Phase 2Results posted
• Phase II Study of Tesetaxel in Metastatic MelanomaCompletedNCT01064713Phase 2Results posted
• Can We Miss Pigmented Lesions in Psoriasis Patients?CompletedNCT01053819Phase 4Results posted
• Dendritic Cells (DC) Vaccine for Metastatic MelanomaTerminatedNCT01042366Phase 2Results posted
• Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With CancerCompletedNCT01037790Phase 2Results posted
• Study to Determine the Effectiveness of GSK1120212 in BRAF Mutation-positive Melanoma Previously Treated With or Without a BRAF InhibitorCompletedNCT01037127Phase 2Results posted
• QUILT-2.008: Study of ALT-801 With Cisplatin in Patients With Metastatic MelanomaTerminatedNCT01029873Phase 1/2Results posted
• A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit MutationCompletedNCT01028222Phase 2Results posted
• Dinaciclib in Treating Patients With Stage III-IV MelanomaTerminatedNCT01026324Phase 1/2Results posted
• Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant MelanomaCompletedNCT01024231Phase 1Results posted
• Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic MelanomaCompletedNCT01014351Phase 2Results posted
• Partner Assistance in Learning and Performing Skin Self-ExaminationCompletedNCT01013844Not applicableResults posted
• Survey Study - Sensitivity Comparison Between MelaFind and Physician GroupCompletedNCT01011153Results posted
• LC Bead Embolization Agent With Doxorubicin in the Treatment Liver Metastasis From MelanomaCompletedNCT01010984Not applicableResults posted
• Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic MelanomaTerminatedNCT01009515Phase 2Results posted
• A Study of Vemurafenib (RO5185426) in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3)CompletedNCT01006980Phase 3Results posted
• A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic MelanomaTerminatedNCT01006252Phase 3Results posted
• Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic MelanomaCompletedNCT01005745Not applicableResults posted
• Measuring Real Time Decision-Making About Ultraviolet Radiation (UVR) ProtectionCompletedNCT01004952Results posted
• A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic MelanomaCompletedNCT01001299Phase 1Results posted
• Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant MelanomaCompletedNCT00976573Phase 2Results posted
• Tumor and Vaccine Site With a Toll Like Receptor (TLR) AgonistCompletedNCT00960752Phase 2Results posted
• A Study of Vemurafenib in Previously Treated Patients With Metastatic MelanomaCompletedNCT00949702Phase 2Results posted
• A Study to Test the Benefit of a New Anti-cancer Treatment in Patients With Unresectable Advanced MelanomaCompletedNCT00942162Phase 2Results posted
• Dinaciclib in Treating Patients With Stage IV MelanomaActive, not recruitingNCT00937937Phase 2Results posted
• Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma PatientsCompletedNCT00936221Phase 2Results posted
• Treatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and PanobinostatTerminatedNCT00925132Phase 1/2Results posted
• Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic MelanomaTerminatedNCT00924001Phase 1/2Results posted
• Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic MelanomaCompletedNCT00923195Phase 2Results posted
• Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced MelanomaCompletedNCT00920907Phase 1Results posted
• Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant MelanomaCompletedNCT00911443Phase 2Results posted
• Study of Gene Modified Immune Cells in Patients With Advanced MelanomaCompletedNCT00910650Phase 2Results posted
• Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous MelanomaCompletedNCT00896480Phase 2Results posted
• Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic MelanomaCompletedNCT00885534Phase 2Results posted
• Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by SurgeryCompletedNCT00866840Phase 2Results posted
• MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00866177Phase 2Results posted
• A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant MelanomaCompletedNCT00864253Phase 3Results posted
• Laboratory-Treated Autologous Lymphocytes and Aldesleukin After Cyclophosphamide and Fludarabine in Treating Patients With Metastatic MelanomaTerminatedNCT00863330Phase 2Results posted
• Pazopanib Hydrochloride in Treating Patients With Metastatic Melanoma That Cannot be Removed by SurgeryCompletedNCT00861913Phase 2Results posted
• A Study of Safety and Clinical Activity of Immunotherapy Plus Chemotherapy in Metastatic Melanoma PatientsTerminatedNCT00849875Phase 2Results posted
• Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant MelanomaCompletedNCT00847522Phase 1/2Results posted
• Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of MelanomaCompletedNCT00841204Phase 2Results posted
• A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic MelanomaCompletedNCT00804908Phase 2Results posted
• Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, DacarbazineCompletedNCT00796991Phase 1Results posted
• A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their TumorTerminatedNCT00796445Phase 3Results posted
• Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged MelanomaCompletedNCT00788775Phase 2Results posted
• Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in MelanomaCompletedNCT00769704Phase 3Results posted
• A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)CompletedNCT00753415Phase 1Results posted
• Efficacy and Safety of High-dose Interferon Alfa-2b (Intron A®) for the Adjuvant Treatment of Malignant Melanoma (Study P04083)CompletedNCT00749684Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By SurgeryCompletedNCT00738361Phase 2Results posted
• 0794GCC: Pentamidine in Treating Patients With Relapsed or Refractory MelanomaTerminatedNCT00729807Phase 2Results posted
• Aldesleukin With or Without Vaccine Therapy in Treating Patients With Stage IV MelanomaCompletedNCT00726739Phase 2Results posted
• Effect of Proactive Management of Side Effects on Treatment Compliance in Malignant Melanoma Patients on High-dose Intron A Therapy (Study P04600)CompletedNCT00723710Results posted
• Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic MelanomaCompletedNCT00715793Phase 1/2Results posted
• Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant MelanomaTerminatedNCT00707161Phase 2Results posted
• Anti-MART-1 F5 Lymphocytes to Treat High-Risk Melanoma PatientsTerminatedNCT00706992Phase 2Results posted
• MAGE-A3 Antigen-Specific Cancer Immunotherapeutic in Patients With Progressive Metastatic Cutaneous MelanomaTerminatedNCT00706238Phase 2Results posted
• Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic CancerTerminatedNCT00704938Phase 2Results posted
• Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By SurgeryCompletedNCT00700882Phase 2Results posted
• Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal MelanomaCompletedNCT00680225Phase 3Results posted
• Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic MelanomaCompletedNCT00679289Phase 2Results posted
• Pilot Trial of "Chemo-Switch" Regimen to Treat Advanced MelanomaTerminatedNCT00673361Phase 2Results posted
• Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and MelanomaCompletedNCT00671918Phase 3Results posted
• Trial of Melaxin Cancer Vaccine Plus Bacillus Calmette-Guerin (BCG) to Treat Malignant MelanomaTerminatedNCT00671554Phase 1/2Results posted

← Melanoma overview